Vischer advised Relief Theraputics on private placement of CHF15 m

Biopharmaceutical company Relief Theraputics Holding, has a binding agreement with two institutional U.S. investors completed. The contract provides for the purchase of Relief shares with a total value of CHF 15 million, which come from Relief’s own shares, which were issued from the authorized share capital, excluding the subscription rights of existing shareholders. The transaction was completed on July 28, 2021.

The advisors

Vischer advised Relief on the Swiss legal aspects of this transaction. The Vischer team was led by partner Robert Bernet (corporate/m&a, pictured) included Peter Kühn (counsel, corporate/m&a) and Christian Schneiter (senior associate, banking & finance).

HC Wainwright & Co. acted as the exclusive placement agent for the offer.